A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System

Inclusion Criteria

• Subjects must be age 22 or older,
• Subjects consenting to undergoing phacoemulsification and IOL implant surgery for the treatment of symptomatic age related lens cataract, and then electing to undergo ZeptoTM capsulotomy,
• Subjects must be willing and able to return for scheduled treatment and follow-up examinations for 3 months.

Exclusion Criteria

• Disease or pathology in the treatment eye that will compromise visual performance or refractive outcome (e.g. previous refractive surgery),
• Zonular abnormality,
• Posterior polar cataract,
• Fellow eye with acuity less than 20/200,
• Any prior ocular surgery of the study eye,
• Pupillary dilation during the pre-operative exam of less than 7 mm in diameter,
• Proliferative diabetic retinopathy,
• Disorders of the ocular muscles, such as nystagmus or strabismus,
• Chronic uveitis,
• Abnormal corneal endothelium,
• Subjects on medications with, in the opinion of the surgeon, significant ocular side effects,
• Pregnant or nursing (lactating) women,
• Implanted ocular device or drug in the study eye,
• Any other condition, which in the judgment of the investigator would prevent the subject from completing the study (e.g. documented diagnosis or treatment for symptoms associated with dementia, mental illness),
• Current participation in another drug or device clinical study, or participation in such a clinical study within the six months.